Citation 1:
    Title: AbbVie cuts 2025 profit forecast on acquisition expenses
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-cuts-2025-profit-forecast-acquisition-expenses-2025-04-03/#:~:text=AbbVie%20has%20lowered%20its%202025,19%20per%20share
    Location: chars 859–1066

Citation 2:
    Title: AbbVie cuts 2025 profit forecast on acquisition expenses
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-cuts-2025-profit-forecast-acquisition-expenses-2025-04-03/#:~:text=AbbVie%20has%20lowered%20its%202025,The%20revised
    Location: chars 1225–1429

Citation 3:
    Title: Abbvie to record $3.5 bln charge related to schizophrenia drug
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-record-35-bln-charge-related-schizophrenia-drug-2025-01-10/#:~:text=AbbVie%20announced%20it%20will%20record,some%20analysts%20projecting%20over%20%241
    Location: chars 1430–1668

Citation 4:
    Title: AbbVie lifts profit forecast on strong sales of newer immunology drugs
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-lifts-profit-forecast-strong-sales-newer-immunology-drugs-2025-04-25/#:~:text=Despite%20declining%20global%20Humira%20sales%2C,However
    Location: chars 1752–1974

Citation 5:
    Title: AbbVie lifts profit forecast on strong sales of newer immunology drugs
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-lifts-profit-forecast-strong-sales-newer-immunology-drugs-2025-04-25/#:~:text=expectations%20in%20the%20first%20quarter%2C,from%20a%20prior%20range%20of
    Location: chars 2159–2399

Citation 6:
    Title: AbbVie lifts profit forecast on strong sales of newer immunology drugs
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-lifts-profit-forecast-strong-sales-newer-immunology-drugs-2025-04-25/#:~:text=expectations%20in%20the%20first%20quarter%2C,from%20a%20prior%20range%20of
    Location: chars 2499–2739

Citation 7:
    Title: AbbVie forecasts 2025 profit above estimates on newer immunology drugs
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-forecasts-2025-profit-above-estimates-driven-by-newer-immunology-drugs-2025-01-31/#:~:text=rose%204.2,drug%20pipeline%20through%20acquisitions%2C%20such
    Location: chars 2817–3057

Citation 8:
    Title: AbbVie forecasts 2025 profit above estimates on newer immunology drugs
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-forecasts-2025-profit-above-estimates-driven-by-newer-immunology-drugs-2025-01-31/#:~:text=rose%204.2,drug%20pipeline%20through%20acquisitions%2C%20such
    Location: chars 3104–3344

Citation 9:
    Title: AbbVie's closely watched schizophrenia drug fails two studies, shares slide
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/abbvies-schizophrenia-drug-misses-main-goals-two-trials-2024-11-11/#:~:text=AbbVie%27s%20shares%20dropped%20over%2012,investor%20concerns%2C%20especially%20as%20the
    Location: chars 3725–3970

Citation 10:
    Title: Abbvie to record $3.5 bln charge related to schizophrenia drug
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-record-35-bln-charge-related-schizophrenia-drug-2025-01-10/#:~:text=AbbVie%20announced%20it%20will%20record,some%20analysts%20projecting%20over%20%241
    Location: chars 3971–4209

Citation 11:
    Title: AbbVie lifts profit forecast on strong sales of newer immunology drugs
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-lifts-profit-forecast-strong-sales-newer-immunology-drugs-2025-04-25/#:~:text=Rinvoq%2C%20which%20it%20expects%20to,from%20possible%20trade%20policy%20changes
    Location: chars 4304–4550

Citation 12:
    Title: AbbVie raises 2024 profit forecast on strong sales of key drugs Skyrizi, Rinvoq
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-raises-2024-profit-forecast-strong-sales-key-drugs-skyrizi-rinvoq-2024-10-30/#:~:text=starting%20in%202026,beginning%20in%20February
    Location: chars 4709–4929

Citation 13:
    Title: AbbVie lifts profit forecast after Skyrizi sales beat expectations
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-raises-annual-profit-forecast-strong-skyrizi-sales-2024-04-26/#:~:text=surpassing%20estimates%20of%20%241,Imbruvica%20also%20outperformed%20expectations
    Location: chars 5859–6099

Citation 14:
    Title: AbbVie says Robert Michael to replace Richard Gonzalez as CEO in July
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-says-richard-gonzalez-step-down-ceo-2024-02-20/#:~:text=to%20the%20role%20of%20Executive,capitalization%20of%20over%20%24300%20billion
    Location: chars 6627–6849

Citation 15:
    Title: AbbVie cuts 2025 profit forecast on acquisition expenses
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-cuts-2025-profit-forecast-acquisition-expenses-2025-04-03/#:~:text=AbbVie%20has%20lowered%20its%202025,The%20revised
    Location: chars 7143–7347

Citation 16:
    Title: AbbVie banks on Alzheimer's therapy with $1.4 billion buy of Aliada
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-buy-alzheimers-therapy-developer-aliada-therapeutics-14-bln-2024-10-28/#:~:text=AbbVie%20announced%20plans%20to%20acquire,of%20AbbVie%27s%20strategy%20to%20diversify
    Location: chars 7348–7601

Citation 17:
    Title: AbbVie forecasts 2025 profit above estimates on newer immunology drugs
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-forecasts-2025-profit-above-estimates-driven-by-newer-immunology-drugs-2025-01-31/#:~:text=rose%204.2,drug%20pipeline%20through%20acquisitions%2C%20such
    Location: chars 8355–8595

Citation 18:
    Title: AbbVie Reports Full-Year and Fourth-Quarter 2023 Financial Results - Feb 2, 2024
    URL: https://news.abbvie.com/2024-02-02-AbbVie-Reports-Full-Year-and-Fourth-Quarter-2023-Financial-Results#:~:text=decrease%20of%2012,8%20percent%20on%20a
    Location: chars 8783–8953

Citation 19:
    Title: AbbVie inks immune disorder drug licensing deal with China's FutureGen
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-inks-immune-disorder-drug-licensing-deal-with-chinas-futuregen-2024-06-13/#:~:text=AbbVie%2C%20a%20U,The%20drug%20is%20currently%20in
    Location: chars 9416–9637

Citation 20:
    Title: AbbVie banks on Alzheimer's therapy with $1.4 billion buy of Aliada
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-buy-alzheimers-therapy-developer-aliada-therapeutics-14-bln-2024-10-28/#:~:text=AbbVie%20announced%20plans%20to%20acquire,of%20AbbVie%27s%20strategy%20to%20diversify
    Location: chars 9775–10028

Citation 21:
    Title: AbbVie lifts profit forecast on strong sales of newer immunology drugs
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-lifts-profit-forecast-strong-sales-newer-immunology-drugs-2025-04-25/#:~:text=Rinvoq%2C%20which%20it%20expects%20to,from%20possible%20trade%20policy%20changes
    Location: chars 10248–10494

Citation 22:
    Title: AbbVie forecasts 2025 profit above estimates on newer immunology drugs
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-forecasts-2025-profit-above-estimates-driven-by-newer-immunology-drugs-2025-01-31/#:~:text=rose%204.2,drug%20pipeline%20through%20acquisitions%2C%20such
    Location: chars 10615–10855

Citation 23:
    Title: AbbVie lifts profit forecast on strong sales of newer immunology drugs
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-lifts-profit-forecast-strong-sales-newer-immunology-drugs-2025-04-25/#:~:text=expectations%20in%20the%20first%20quarter%2C,from%20a%20prior%20range%20of
    Location: chars 11737–11977

Citation 24:
    Title: AbbVie forecasts 2025 profit above estimates on newer immunology drugs
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-forecasts-2025-profit-above-estimates-driven-by-newer-immunology-drugs-2025-01-31/#:~:text=rose%204.2,drug%20pipeline%20through%20acquisitions%2C%20such
    Location: chars 12011–12251

Citation 25:
    Title: AbbVie forecasts 2025 profit above estimates on newer immunology drugs
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-forecasts-2025-profit-above-estimates-driven-by-newer-immunology-drugs-2025-01-31/#:~:text=rose%204.2,drug%20pipeline%20through%20acquisitions%2C%20such
    Location: chars 12320–12560

Citation 26:
    Title: AbbVie raises 2024 profit forecast on strong sales of key drugs Skyrizi, Rinvoq
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-raises-2024-profit-forecast-strong-sales-key-drugs-skyrizi-rinvoq-2024-10-30/#:~:text=starting%20in%202026,beginning%20in%20February
    Location: chars 12741–12961

Citation 27:
    Title: Abbvie to record $3.5 bln charge related to schizophrenia drug
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-record-35-bln-charge-related-schizophrenia-drug-2025-01-10/#:~:text=AbbVie%20announced%20it%20will%20record,some%20analysts%20projecting%20over%20%241
    Location: chars 13739–13977

Citation 28:
    Title: Abbvie to record $3.5 bln charge related to schizophrenia drug
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-record-35-bln-charge-related-schizophrenia-drug-2025-01-10/#:~:text=adjusted%20profit%20forecast%20downward%20due,earnings%20report%20is%20expected%20on
    Location: chars 14018–14258

Citation 29:
    Title: AbbVie lifts profit forecast on strong sales of newer immunology drugs
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-lifts-profit-forecast-strong-sales-newer-immunology-drugs-2025-04-25/#:~:text=Rinvoq%2C%20which%20it%20expects%20to,The%20raised%20forecast%20excludes%20any
    Location: chars 14482–14726

Citation 30:
    Title: AbbVie lifts profit forecast after Skyrizi sales beat expectations
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-raises-annual-profit-forecast-strong-skyrizi-sales-2024-04-26/#:~:text=surpassing%20estimates%20of%20%241,Imbruvica%20also%20outperformed%20expectations
    Location: chars 15335–15575

Citation 31:
    Title: AbbVie lifts profit forecast after Skyrizi sales beat expectations
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-raises-annual-profit-forecast-strong-skyrizi-sales-2024-04-26/#:~:text=surpassing%20estimates%20of%20%241,Imbruvica%20also%20outperformed%20expectations
    Location: chars 16185–16425

Citation 32:
    Title: AbbVie forecasts 2025 profit above estimates on newer immunology drugs
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-forecasts-2025-profit-above-estimates-driven-by-newer-immunology-drugs-2025-01-31/#:~:text=rose%204.2,drug%20pipeline%20through%20acquisitions%2C%20such
    Location: chars 16426–16666

Citation 33:
    Title: AbbVie Reports Full-Year and Fourth-Quarter 2023 Financial Results - Feb 2, 2024
    URL: https://news.abbvie.com/2024-02-02-AbbVie-Reports-Full-Year-and-Fourth-Quarter-2023-Financial-Results#:~:text=%2A%20Delivers%20Full,2%20Percent%20on%20an
    Location: chars 16895–17069

Citation 34:
    Title: AbbVie Reports Full-Year and Fourth-Quarter 2023 Financial Results - Feb 2, 2024
    URL: https://news.abbvie.com/2024-02-02-AbbVie-Reports-Full-Year-and-Fourth-Quarter-2023-Financial-Results#:~:text=,8%20percent
    Location: chars 17406–17549

Citation 35:
    Title: Abbvie to record $3.5 bln charge related to schizophrenia drug
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-record-35-bln-charge-related-schizophrenia-drug-2025-01-10/#:~:text=AbbVie%20announced%20it%20will%20record,some%20analysts%20projecting%20over%20%241
    Location: chars 18754–18992

Citation 36:
    Title: AbbVie's closely watched schizophrenia drug fails two studies, shares slide
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/abbvies-schizophrenia-drug-misses-main-goals-two-trials-2024-11-11/#:~:text=AbbVie%27s%20shares%20dropped%20over%2012,investor%20concerns%2C%20especially%20as%20the
    Location: chars 19028–19273

Citation 37:
    Title: AbbVie lifts profit forecast on strong sales of newer immunology drugs
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-lifts-profit-forecast-strong-sales-newer-immunology-drugs-2025-04-25/#:~:text=Rinvoq%2C%20which%20it%20expects%20to,from%20possible%20trade%20policy%20changes
    Location: chars 19583–19829

Citation 38:
    Title: AbbVie raises 2024 profit forecast on strong sales of key drugs Skyrizi, Rinvoq
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-raises-2024-profit-forecast-strong-sales-key-drugs-skyrizi-rinvoq-2024-10-30/#:~:text=starting%20in%202026,beginning%20in%20February
    Location: chars 20532–20752

Citation 39:
    Title: Abbvie to record $3.5 bln charge related to schizophrenia drug
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-record-35-bln-charge-related-schizophrenia-drug-2025-01-10/#:~:text=adjusted%20profit%20forecast%20downward%20due,earnings%20report%20is%20expected%20on
    Location: chars 20968–21208

Citation 40:
    Title: Mounting lawsuits allege AbbVie abused the drug patent system
    URL: https://www.axios.com/2019/04/03/abbvie-humira-patent-thicket-lawsuits-unions-workers#:~:text=AbbVie%20is%20facing%20a%20growing,could%20become%20a%20major%20legal
    Location: chars 22773–22955

Citation 41:
    Title: Mounting lawsuits allege AbbVie abused the drug patent system
    URL: https://www.axios.com/2019/04/03/abbvie-humira-patent-thicket-lawsuits-unions-workers#:~:text=AbbVie%20is%20facing%20a%20growing,could%20become%20a%20major%20legal
    Location: chars 23840–24022

Citation 42:
    Title: AbbVie cuts 2025 profit forecast on acquisition expenses
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-cuts-2025-profit-forecast-acquisition-expenses-2025-04-03/#:~:text=AbbVie%20has%20lowered%20its%202025,19%20per%20share
    Location: chars 25747–25954

Citation 43:
    Title: AbbVie lifts profit forecast on strong sales of newer immunology drugs
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-lifts-profit-forecast-strong-sales-newer-immunology-drugs-2025-04-25/#:~:text=AbbVie%20raised%20its%202025%20profit,from%20a%20prior%20range%20of
    Location: chars 26205–26438

Citation 44:
    Title: AbbVie cuts 2024 profit forecast on acquisition expenses
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-cuts-2024-profit-forecast-acquisition-expenses-2025-01-06/#:~:text=AbbVie%20has%20revised%20its%202024,its%20flagship%20arthritis%20drug%2C%20Humira
    Location: chars 26663–26899

Citation 45:
    Title: AbbVie's closely watched schizophrenia drug fails two studies, shares slide
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/abbvies-schizophrenia-drug-misses-main-goals-two-trials-2024-11-11/#:~:text=AbbVie%27s%20shares%20dropped%20over%2012,investor%20concerns%2C%20especially%20as%20the
    Location: chars 27146–27391

Citation 46:
    Title: Abbvie to record $3.5 bln charge related to schizophrenia drug
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-record-35-bln-charge-related-schizophrenia-drug-2025-01-10/#:~:text=AbbVie%20announced%20it%20will%20record,some%20analysts%20projecting%20over%20%241
    Location: chars 27624–27862

Citation 47:
    Title: AbbVie banks on Alzheimer's therapy with $1.4 billion buy of Aliada
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-buy-alzheimers-therapy-developer-aliada-therapeutics-14-bln-2024-10-28/#:~:text=AbbVie%20announced%20plans%20to%20acquire,of%20AbbVie%27s%20strategy%20to%20diversify
    Location: chars 28112–28365

Citation 48:
    Title: AbbVie inks immune disorder drug licensing deal with China's FutureGen
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-inks-immune-disorder-drug-licensing-deal-with-chinas-futuregen-2024-06-13/#:~:text=AbbVie%2C%20a%20U,The%20drug%20is%20currently%20in
    Location: chars 28621–28842

Citation 49:
    Title: AbbVie forecasts 2025 profit above estimates on newer immunology drugs
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-forecasts-2025-profit-above-estimates-driven-by-newer-immunology-drugs-2025-01-31/#:~:text=rose%204.2,drug%20pipeline%20through%20acquisitions%2C%20such
    Location: chars 29106–29346

Citation 50:
    Title: AbbVie lifts profit forecast after Skyrizi sales beat expectations
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-raises-annual-profit-forecast-strong-skyrizi-sales-2024-04-26/#:~:text=share%2C%20up%20from%20its%20earlier,Imbruvica%20also%20outperformed%20expectations
    Location: chars 29586–29828

Citation 51:
    Title: AbbVie raises 2024 profit forecast on strong sales of key drugs Skyrizi, Rinvoq
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-raises-2024-profit-forecast-strong-sales-key-drugs-skyrizi-rinvoq-2024-10-30/#:~:text=its%20newer%20immunology%20drugs%2C%20Skyrizi,about%20future%20Medicare%20pricing%20cuts
    Location: chars 30074–30336

Citation 52:
    Title: AbbVie says Robert Michael to replace Richard Gonzalez as CEO in July
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-says-richard-gonzalez-step-down-ceo-2024-02-20/#:~:text=to%20the%20role%20of%20Executive,capitalization%20of%20over%20%24300%20billion
    Location: chars 30565–30787

Citation 53:
    Title: Mounting lawsuits allege AbbVie abused the drug patent system
    URL: https://www.axios.com/2019/04/03/abbvie-humira-patent-thicket-lawsuits-unions-workers#:~:text=AbbVie%20is%20facing%20a%20growing,could%20become%20a%20major%20legal
    Location: chars 30976–31158

